Marosi C - Search Results

1

GM-CSF in the treatment of a patient with severe methotrexate intoxication.

Steger GG, Mader RM, Gnant MF, Marosi C, Lenz K, Jakesz R. Steger GG, et al. Among authors: marosi c. J Intern Med. 1993 Jun;233(6):499-502. doi: 10.1111/j.1365-2796.1993.tb01006.x. J Intern Med. 1993. PMID: 8501421

2

MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphoma.

Marosi C, Heinz R, Steger G, Fortelny A, Chott A, Hanak H, Radaszkiewicz T, Baur M, Kreiner G, Schwarzinger I, et al. Marosi C, et al. J Cancer Res Clin Oncol. 1992;118(4):314-7. doi: 10.1007/BF01208622. J Cancer Res Clin Oncol. 1992. PMID: 1374411 Clinical Trial.

3

Simultaneous occurrence of t(14;18) and t(8;22) common acute lymphoblastic leukemia.

Marosi C, Bettelheim P, Chott A, Köller U, Kreiner G, Steger G, Jäger U, Pirc-Danoewinata H, Lechner K. Marosi C, et al. Ann Hematol. 1992 Feb;64(2):101-4. doi: 10.1007/BF01715354. Ann Hematol. 1992. PMID: 1554791

4

Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML.

Marosi C, Köller U, Koller-Weber E, Schwarzinger I, Schneider B, Jäger U, Vahls P, Nowotny H, Pirc-Danoewinata H, Steger G, et al. Marosi C, et al. Cancer Genet Cytogenet. 1992 Jul 1;61(1):14-25. doi: 10.1016/0165-4608(92)90364-e. Cancer Genet Cytogenet. 1992. PMID: 1638477

5

[5-Fluorouracil (5-FU)/leucovorin in comparison to other current chemotherapy protocols in metastasizing colorectal carcinoma].

Baur M, Schlappack O, Havelec L, Mader R, Marosi C, Scheithauer W, Dittrich C. Baur M, et al. Among authors: marosi c. Wien Klin Wochenschr. 1991;103(11):332-9. Wien Klin Wochenschr. 1991. PMID: 1858384 Review. German.

6

Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer.

Fiegl M, Tueni C, Schenk T, Jakesz R, Gnant M, Reiner A, Rudas M, Pirc-Danoewinata H, Marosi C, Huber H, et al. Fiegl M, et al. Among authors: marosi c. Br J Cancer. 1995 Jul;72(1):51-5. doi: 10.1038/bjc.1995.276. Br J Cancer. 1995. PMID: 7599066 Free PMC article.

7

New mucin-like cancer-associated antigens (CA M 26, CA M 29 and CA 549) and a new proliferation marker (TPS) in patients with primary or advanced breast cancer.

Locker GJ, Mader RM, Braun J, Sieder AE, Marosi C, Rainer H, Jakesz R, Steger GG. Locker GJ, et al. Among authors: marosi c. Oncology. 1995 Mar-Apr;52(2):140-4. doi: 10.1159/000227445. Oncology. 1995. PMID: 7854774

8

Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administration.

Steger GG, Mader RM, Djavanmard MP, Gnant MF, Locker G, Marosi C, Rainer H, Jakesz R. Steger GG, et al. Among authors: marosi c. J Cancer Res Clin Oncol. 1994;120(5):314-8. doi: 10.1007/BF01236390. J Cancer Res Clin Oncol. 1994. PMID: 8126062 Clinical Trial.

9

Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients.

Locker GJ, Wenzel C, Schmidinger M, Gnant MF, Marosi C, Jakesz R, Zielinski CC, Steger GG. Locker GJ, et al. Among authors: marosi c. Anticancer Drugs. 2001 Mar;12(3):209-12. doi: 10.1097/00001813-200103000-00006. Anticancer Drugs. 2001. PMID: 11290868

10

Preliminary study on pharmacokinetics of dacarbazine and fotemustine in glioblastoma multiforme patients does not indicate gender-specific differences.

Fazeny-Dörner B, Mader RM, Piribauer M, Rizovski B, Stögermaier B, Marosi C. Fazeny-Dörner B, et al. Among authors: marosi c. Anticancer Drugs. 2004 Jun;15(5):495-8. Anticancer Drugs. 2004. PMID: 15166624 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters